Safety and Efficacy of Amiodarone in a Patient With COVID-19
Fecha
2020Autor
Castaldo, Nadia
Aimo, Alberto
Castiglione, Vincenzo
Padalino, Cristiano
Emdin, Michele
Resumen
There is an urgent need for effective treatments for coronavirus disease-2019 (COVID-19). Amiodarone, like hydroxychloroquine, exerts antiviral actions by interfering with endocytosis and viral replication. Here, to our knowledge, we
report the first case of a patient affected by respiratory failure related to COVID-19 who recovered after only supportive
measures and a short amiodarone course. (Level of Difficulty: Beginner.) (J Am Coll Cardiol Case Rep 2020;2:1307–10)
Palabras clave
CAD; COVID-19; SARS-CoV-2Enlace al recurso
https://doi.org/10.1016/j.jaccas.2020.04.053Colecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.